Wall Street is positive on Novocure Ltd (NVCR). On average, analysts give Novocure Ltd a Buy rating. The average price target is $29.428, which means analysts expect the stock to gain by 156.34% over the next twelve months. That average ranking earns Novocure Ltd an Analyst Rating of 33, which is better than 33% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating NVCR a Buy today. Find out what this means to you and get the rest of the rankings on NVCR!